Objective To observe the efficacy and safety of vildagliptin combined with acarbose in
treating type 2 diabetes. Methods 78 patients with type 2 diabetes were divided into two …

Background: Many treatment options are available for type 2 diabetes mellitus (T2DM), but
long-term glucose control remains unsatisfactory. Vildagliptin is a highly selective DDP-4 …

Objectives To compare the safety and efficacy of combination of Glimepiride-Metformin with
Vildagliptin-Metformin in type 2 diabetic patients with HbA1c between 7.5 to10. Methods A …

The aim of this study was to assess the efficacy of a combination therapy of vildagliptin plus
an α-glucosidase inhibitor for patients with type II diabetes mellitus. Type II diabetic patients …

Introduction: In order to prevent the specific diabetes mellitus related macrovascular and
microvascular complications, guidelines by American Diabetes Association recommend a …

Background Vildagliptin is a dipeptidyl peptidase-4 inhibitor used to treat diabetes mellitus.
No bioequivalence study data have been published for the Indian population comparing …

Determination of the anti-diabetic drugs vildagliptin and metformin is wildly used to validate
drug efficiency in diabetic patients. Here we describe a new and simple chromatographic …

Background: Diabetes mellitus is a prevalent disease, and its burden has increased over the
years which is going to cross 134 million cases by 2045, despite the available treatments …

AIM: To evaluate the efficacy and safety of the addition of vildagliptin to low-dose metformin
and compare it to an uptitration of metformin in type 2 diabetes mellitus (T2DM) patients who …